[{"orgOrder":0,"company":"Hirschfeld Oncology","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"U.S.A","productType":"Miscellaneous","year":"2024","type":"Inapplicable","leadProduct":"Glipizide","moa":"Sulfonylurea receptor 1, Kir6.2","graph1":"Oncology","graph2":"Phase II","graph3":"Hirschfeld Oncology","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Hirschfeld Oncology \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"Hirschfeld Oncology \/ Undisclosed"}]
Find Clinical Drug Pipeline Developments & Deals for Glucotrol XL, Glucotrol, Glipizide
Filters
×
FILTER:
Company Name
Year
DEALS // DEV.
Country
Sponsor
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Reset All
